Cargando…
Patient factors and their impact on neutropenic events: a systematic review and meta-analysis
BACKGROUND: Neutropenia is associated with an increased risk of mortality and hospitalisation. Strategies, including the prescribing of colony-stimulating growth factors (CSFs), are adopted when a high risk (> 20%) of neutropenic complications are seen in the clinical trial setting. With a divers...
Autores principales: | Chambers, Pinkie, Jani, Yogini, Wei, Li, Kipps, Emma, Forster, Martin D., Wong, Ian C. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541585/ https://www.ncbi.nlm.nih.gov/pubmed/30993453 http://dx.doi.org/10.1007/s00520-019-04773-6 |
Ejemplares similares
-
Evidence to guide the optimal timing for pre‐chemotherapy blood tests for early breast, colorectal cancer and diffuse large B‐cell lymphoma
por: Chambers, Pinkie, et al.
Publicado: (2021) -
Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study
por: Jamieson, Liz, et al.
Publicado: (2020) -
Development and validation of a risk score (Delay-7) to predict the occurrence of a treatment delay following cycle 1 chemotherapy
por: Chambers, P., et al.
Publicado: (2022) -
Histamine‐2 (H(2)) antagonists can be safely removed from standard paclitaxel premedication regimens
por: Foreman, Emma, et al.
Publicado: (2022) -
Neutropenic Fever
por: Baluch, Aliyah, et al.
Publicado: (2019)